Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell RCC”

530 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 530 results

Early research (Phase 1)Temporarily pausedNCT06649682
What this trial is testing

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00496756
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Nebraska 14
Not applicableNot Yet RecruitingNCT07776483
What this trial is testing

Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
West China Hospital 67
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07488572
What this trial is testing

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03635892
What this trial is testing

Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced or Metastatic Non-clear Cell Renal Cell CarcinomaUnclassified Renal Cell CarcinomaPapillary Renal Cell Carcinoma+4 more
Memorial Sloan Kettering Cancer Center 60
Not applicableActive Not RecruitingNCT05782400
What this trial is testing

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 100
Large-scale testing (Phase 3)Study completedNCT03138512
What this trial is testing

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Who this might be right for
Carcinoma, Renal Cell
Bristol-Myers Squibb 1,641
Large-scale testing (Phase 3)Study completedNCT00087022
What this trial is testing

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Heidelberg Pharma AG 864
Very early researchStudy completedNCT02626130
What this trial is testing

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Testing effectiveness (Phase 2)Looking for participantsNCT06699602
What this trial is testing

Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT00459979
What this trial is testing

Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT00293527
What this trial is testing

Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

Who this might be right for
Renal Cancer
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680
What this trial is testing

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT02771626
What this trial is testing

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)Looking for participantsNCT06750185
What this trial is testing

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 248
Testing effectiveness (Phase 2)UnknownNCT05879510
What this trial is testing

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 63
Large-scale testing (Phase 3)Active Not RecruitingNCT01575548
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 129
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Next Page